Tocilizumab in COVID-19 therapy: who benefits, and how? – Authors' reply

Detalles Bibliográficos
Autores principales: Horby, Peter, Staplin, Natalie, Haynes, Richard, Landray, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298006/
https://www.ncbi.nlm.nih.gov/pubmed/34303433
http://dx.doi.org/10.1016/S0140-6736(21)01422-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8298006/
https://www.ncbi.nlm.nih.gov/pubmed/34303433
http://dx.doi.org/10.1016/S0140-6736(21)01422-7

Ejemplares similares